JPMorgan Chase & Co. Buys 34,354 Shares of ZimVie Inc. (NASDAQ:ZIMV)

JPMorgan Chase & Co. grew its holdings in shares of ZimVie Inc. (NASDAQ:ZIMV - Free Report) by 18.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 217,773 shares of the company's stock after purchasing an additional 34,354 shares during the quarter. JPMorgan Chase & Co. owned approximately 0.79% of ZimVie worth $3,038,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in the business. SG Americas Securities LLC raised its position in ZimVie by 15.7% in the fourth quarter. SG Americas Securities LLC now owns 11,110 shares of the company's stock worth $155,000 after acquiring an additional 1,508 shares during the period. EMC Capital Management raised its holdings in shares of ZimVie by 47.0% in the 4th quarter. EMC Capital Management now owns 13,802 shares of the company's stock worth $193,000 after purchasing an additional 4,414 shares during the period. Principal Financial Group Inc. lifted its stake in ZimVie by 9.8% in the fourth quarter. Principal Financial Group Inc. now owns 19,054 shares of the company's stock valued at $266,000 after purchasing an additional 1,702 shares during the last quarter. Bailard Inc. grew its holdings in ZimVie by 35.0% during the fourth quarter. Bailard Inc. now owns 21,194 shares of the company's stock valued at $296,000 after purchasing an additional 5,494 shares during the period. Finally, Fox Run Management L.L.C. purchased a new stake in ZimVie in the fourth quarter worth $463,000. 95.63% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research analysts have recently weighed in on ZIMV shares. Needham & Company LLC reiterated a "hold" rating on shares of ZimVie in a research note on Wednesday, April 9th. B. Riley began coverage on shares of ZimVie in a research report on Thursday, April 10th. They set a "buy" rating and a $16.00 target price for the company.

ZimVie Stock Performance

Shares of ZimVie stock traded up $0.02 during trading hours on Friday, reaching $9.44. The company had a trading volume of 76,656 shares, compared to its average volume of 222,207. The firm has a market cap of $262.88 million, a PE ratio of -0.72 and a beta of 2.14. ZimVie Inc. has a one year low of $8.56 and a one year high of $22.40. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.94 and a quick ratio of 1.38. The business has a fifty day simple moving average of $11.16 and a 200 day simple moving average of $13.07.

ZimVie (NASDAQ:ZIMV - Get Free Report) last announced its quarterly earnings results on Wednesday, February 26th. The company reported $0.27 earnings per share for the quarter, beating the consensus estimate of $0.25 by $0.02. The firm had revenue of $111.52 million for the quarter, compared to analysts' expectations of $113.67 million. ZimVie had a positive return on equity of 2.90% and a negative net margin of 77.31%. On average, analysts anticipate that ZimVie Inc. will post 0.6 earnings per share for the current fiscal year.

ZimVie Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.